Company / Total Assets
Insulet Corporation Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.2B
FY2025
5-year range
$2.0B / $3.2B
FY2021-FY2025
Trend
+3.3%
vs FY2024
Sector context
#79 of 166
Health Care
What the data says
At $3.2B, Insulet Corporation's total assets ranks #79 of 166 in the Health Care sector. Total Assets has increased for 9 consecutive years, from $457M in FY2016 to $3.2B in FY2025.
Based on SEC 10-K filings.
$3.2B in FY2025 with a 5-year CAGR of +11.2%.
Improved from $2.6B to $3.2B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
#79 of 166 in Health CareTop 48% of 166This company $3.2B Sector average $15.0B
▼
-78.7% below sector average
Key checks
Key Insights
- Insulet Corporation's total assets has grown for 9 consecutive years.
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2025, total assets increased 3.3% year-over-year.
- Ranks #79 out of 166 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.2B | +3.3% |
| FY2024 | $3.1B | +19.3% |
| FY2023 | $2.6B | +15.0% |
| FY2022 | $2.3B | +9.9% |
| FY2021 | $2.0B | +9.4% |
| FY2020 | $1.9B | +63.9% |
| FY2019 | $1.1B | +23.1% |
| FY2018 | $928.7M | +13.7% |
| FY2017 | $816.7M | +78.9% |
| FY2016 | $456.6M | +66.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026